Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Pulmonary Disease, Chronic ObstructiveAsthmaAdverse Effect of Beta-adrenoreceptor Antagonists
Interventions
DRUG

Metoprolol succinate ER

Cardioselective beta-blocker

DRUG

Carvedilol

Non-cardioselective beta-blocker

Trial Locations (1)

90073

VA West Los Angeles Medical Center, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

VA Greater Los Angeles Healthcare System

FED